Dr. Jeffrey Allen is an associate professor in the Department of Neurology at the University of Minnesota. He speaks about CIDP and some of the treatment options available with patients and other healthcare professionals.
Discover the freedom and flexibility self-infusing with Hizentra can offer PI & CIDP patients, and their caregivers. Learn more about the latest Hizentra innovations and news, patient stories and support programs, and more: https://www.hizentra.com
WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.
If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.
See your doctor for a full explanation, and the full prescribing information for complete boxed warning.
Please see full Important Safety Information at the end of this video, and view the full Prescribing Information here: http://bit.ly/HIZ_PI
Please subscribe to the Hizentra YouTube channel here: https://bit.ly/3ecGE5C
View the Hizentra PI Facebook page here: https://www.facebook.com/HizentraPI/
View the Hizentra CIDP Facebook page here: https://www.facebook.com/hizentracidp/